Vosoritide

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Collagen-binding C-type natriuretic peptide enhances chondrogenesis and osteogenesis.

Collagen-binding C-type natriuretic peptide enhances chondrogenesis and osteogenesis.

Journal: JCI insight

Published: December 23, 2025

Effect of Vosoritide therapy on IGF-I and Endogenous C-type Natriuretic Peptide in Hypochondroplasia.

Effect of Vosoritide therapy on IGF-I and Endogenous C-type Natriuretic Peptide in Hypochondroplasia.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 07, 2025

Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report.

Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report.

Journal: Hormone research in paediatrics

Published: September 02, 2025

Real-world outcomes of vosoritide in achondroplasia: A systematic review and meta-analysis of multinational clinical evidence.

Real-world outcomes of vosoritide in achondroplasia: A systematic review and meta-analysis of multinational clinical evidence.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 28, 2025

Homozygous Achondroplasia With Long-Term Survival: Growth Patterns, Medical Interventions, and Practice Implications.

Homozygous Achondroplasia With Long-Term Survival: Growth Patterns, Medical Interventions, and Practice Implications.

Journal: American journal of medical genetics. Part A

Published: August 26, 2025

Real-world safety and age-dependent effectiveness of vosoritide in achondroplasia: A single-center retrospective analysis of transition from growth hormone to vosoritide.

Real-world safety and age-dependent effectiveness of vosoritide in achondroplasia: A single-center retrospective analysis of transition from growth hormone to vosoritide.

Journal: Bone

Published: August 06, 2025

Genetics of short stature.

Genetics of short stature.

Journal: Current opinion in pediatrics

Published: July 14, 2025

C-type natriuretic peptide as mediator of growth in the absence of growth hormone: Unraveling the mystery of the growth without GH syndrome.

C-type natriuretic peptide as mediator of growth in the absence of growth hormone: Unraveling the mystery of the growth without GH syndrome.

Journal: Hormones (Athens, Greece)

Published: June 10, 2025

Vosoritide (Voxzogo) for Achondroplasia: A Review of Clinical and Real-World Evidence.

Vosoritide (Voxzogo) for Achondroplasia: A Review of Clinical and Real-World Evidence.

Journal: Cureus

Published: June 06, 2025

Changes in the Alignment of the Spine and Lower Limb in Children With Achondroplasia Treated With Vosoritide: A Single-center, 1-year Follow-up Prospective Study.

Changes in the Alignment of the Spine and Lower Limb in Children With Achondroplasia Treated With Vosoritide: A Single-center, 1-year Follow-up Prospective Study.

Journal: Journal of pediatric orthopedics

Published: April 15, 2025

Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide.

Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide.

Journal: Genetics in medicine open

Published: April 05, 2025

Real-World Safety and Effectiveness of Vosoritide in Achondroplasia: Results from a Single Center in Portugal.

Real-World Safety and Effectiveness of Vosoritide in Achondroplasia: Results from a Single Center in Portugal.

Journal: Advances in therapy

Published: March 03, 2025

Showing 1-12 of 79

Last Updated: 02/24/2026